Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 29

Results For "public-health"

545 News Found

Mandaviya inaugurates CDSCO Sub Zonal Office and Central Drug Testing Laboratory in Indore
News | January 08, 2024

Mandaviya inaugurates CDSCO Sub Zonal Office and Central Drug Testing Laboratory in Indore

Lays Foundation Stone of 6 new facilities at AIIMS Bhopal and inaugurates a slew of facilities in Madhya Pradesh


Mandaviya lays foundation stone for NCDC regional branch, state branches and 2 BSL-3 laboratories
Policy | January 03, 2024

Mandaviya lays foundation stone for NCDC regional branch, state branches and 2 BSL-3 laboratories

Dedicates upgraded National Centre for Disease Control, Delhi and a Temporary Regional Branch of NCDC to the nation


Developing entrepreneurship in Ayush Sector is a priority area: Ayush Minister
Policy | December 02, 2023

Developing entrepreneurship in Ayush Sector is a priority area: Ayush Minister

Global Ayurveda Festival organising in Thiruvananthapuram from 1st to 5th December


AstraZeneca Pharma appoints Venkat Natarajan as Lead - Market Access
People | December 02, 2023

AstraZeneca Pharma appoints Venkat Natarajan as Lead - Market Access

Currently, Venkat is Lead – Market Access, India at Pfizer


Health Minister Mandaviya delivers keynote address 2nd Voice of Global South Summit 2023
Policy | November 20, 2023

Health Minister Mandaviya delivers keynote address 2nd Voice of Global South Summit 2023

Emphasizes the need for a collective effort on bolstering resilience across economies, societies, healthcare systems, education systems and infrastructure


Zydus, Guardant Health to promote Guardant360 genomic tests for cancers in India and Nepal
Healthcare | November 04, 2023

Zydus, Guardant Health to promote Guardant360 genomic tests for cancers in India and Nepal

The agreement demonstrates a shared commitment to advance precision medicine and improve patient outcomes in the region


USFDA accepts for review AstraZeneca’s supplemental biologics license application for self-administration of FluMist Quadrivalent
Drug Approval | October 26, 2023

USFDA accepts for review AstraZeneca’s supplemental biologics license application for self-administration of FluMist Quadrivalent

The sBLA is supported by a usability study which confirmed that individuals over 18 years of age could self-administer


75% of newly emerging infectious diseases over last three decades are zoonotic in nature: Union Health Secretary
Public Health | October 19, 2023

75% of newly emerging infectious diseases over last three decades are zoonotic in nature: Union Health Secretary

Pant delivers keynote address at National Conclave on “Augmented Zoonotic Diseases Surveillance at Human – Wildlife Interface”